Johns Hopkins University
CompanyUnited StatesFounded 1876
Johns Hopkins University develops one asset, in phase 2 (pegsebrenatide in Parkinson's disease). Mostly peptide acting on GLP1R; based in the United States, founded in 1876.
- 1
- Asset
- Furthest stage
- Phase 2
- 1,575
- Grants
- 412
- Trials
- 55
- Signals
Pipeline
1Activates GLP-1 receptors to suppress microglial activation and neuroinflammation.
Phase 2, Peptide, GLP1R, Parkinson's disease, multiple sclerosis
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms2
- Trials523
- Deals1
- People24
- Signals20
- Integrity notices10
- Similar companies6
Papers
Next research., Nov 21, 2026
AJE advances : research in epidemiology, Nov 20, 2026
Research Square, Nov 19, 2026
medRxiv, Nov 19, 2026
Epigenetics drives oocyte aging: from mechanisms to interventions
npj aging, Nov 19, 2026
Arquivos brasileiros de cardiologia, Nov 18, 2026
Sleep and Aging: Understanding Changes and Promoting Healthy Sleep in Older Adults
Neurologic clinics, Nov 18, 2026
Psychological Assets and Cardiovascular Health in Adulthood: A Mixed Methods Investigation
Journal of the American Heart Association, Nov 18, 2026
Estimated breast screening gains were small in older women
Journal of the National Cancer Institute, Nov 18, 2026
Toward a Healthier Future Through Obesity Prevention and Care: The JAMA Summit Report on Obesity
JAMA, Nov 17, 2026
Radiology advances, Nov 17, 2026
BMC women's health, Nov 16, 2026
Model improves heart risk prediction in lung screening
arXiv, Nov 16, 2026
Overall ultraprocessed food intake showed no clear link to death risk
Current developments in nutrition, Nov 15, 2026
Breast cancer research and treatment, Nov 14, 2026
Wearable‐Derived Physical Activity Patterns in Preclinical and Clinical Obesity
Obesity (Silver Spring, Md.), Nov 14, 2026
JCO precision oncology, Nov 13, 2026
Medicine, Nov 13, 2026
Brain scan model performs best in dementia detection tests
Communications medicine, Nov 13, 2026
The Chilean harmonized cognitive assessment protocol (Chile-Cog): study design
BMC public health, Nov 12, 2026